Business Context and Reporting Period
Dyadic International, Inc. (DYAI) filed a Form 8-K on July 17, 2025, reporting a deficiency notice received from The Nasdaq Stock Market LLC. The Company is a Delaware corporation focused on microbial protein production platforms and related technologies.
Key Financial Metrics
This filing does not contain specific financial statements, revenue, profit, cash flow, or debt figures. The document references the Company's history of net losses as a risk factor but does not provide current quantitative values for liquidity or margins.
Material Changes and Listing Status
- Minimum Bid Price Deficiency: The Company's common stock has traded below the $1.00 minimum bid price requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
- Compliance Timeline: The Company has 180 calendar days, until January 13, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- Market Value Deficiency: The Company remains out of compliance with the $35 million minimum Market Value of Listed Securities (MVLS) requirement under Nasdaq Listing Rule 5550(b)(2), with a separate compliance deadline of December 20, 2025.
- Delisting Risk: Failure to cure either deficiency by the respective deadlines could result in the delisting of the Company's common stock from the Nasdaq Capital Market.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the bid price and evaluate options to resolve the deficiencies. The filing includes a Safe Harbor statement regarding forward-looking statements, noting significant risks including:
- History of net losses and ongoing capital needs.
- Ability to maintain compliance with other Nasdaq listing standards.
- Market and regulatory acceptance of microbial protein production platforms.
- Competition, reliance on third parties, and results of nonclinical studies and clinical trials.
There is no assurance that an appeal of a potential delisting determination would be successful.
Investor Verification Checklist
- Verify the current trading price of DYAI to assess the gap from the $1.00 compliance threshold.
- Review the Company's most recent 10-K or 10-Q for details on cash reserves and capital raising activities needed to address the MVLS deficiency.
- Monitor for any announcements regarding stock splits or other corporate actions intended to address the bid price deficiency.
- Check for updates on the December 20, 2025, deadline for the Market Value of Listed Securities requirement.